EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,257,956 | -14.9% | 68,816 | -1.6% | 0.02% | -19.0% |
| Q3 2021 | $1,477,834 | +12.6% | 69,907 | -2.9% | 0.02% | +16.7% |
| Q2 2021 | $1,311,931 | -10.3% | 72,005 | +11.2% | 0.02% | -18.2% |
| Q1 2021 | $1,462,861 | +17.8% | 64,757 | +4.7% | 0.02% | +15.8% |
| Q4 2020 | $1,241,912 | -19.5% | 61,879 | -2.0% | 0.02% | -29.6% |
| Q3 2020 | $1,543,064 | -1.4% | 63,111 | -4.2% | 0.03% | -3.6% |
| Q2 2020 | $1,564,727 | +5.2% | 65,911 | -23.7% | 0.03% | -12.5% |
| Q1 2020 | $1,487,567 | -7.3% | 86,386 | -5.1% | 0.03% | +18.5% |
| Q4 2019 | $1,604,248 | +0.3% | 91,047 | +0.6% | 0.03% | 0.0% |
| Q3 2019 | $1,599,874 | -25.6% | 90,465 | -10.1% | 0.03% | -25.0% |
| Q2 2019 | $2,149,437 | -10.3% | 100,582 | -0.0% | 0.04% | -16.3% |
| Q1 2019 | $2,395,042 | +20.8% | 100,632 | -0.2% | 0.04% | +7.5% |
| Q4 2018 | $1,983,110 | +11.4% | 100,819 | +0.4% | 0.04% | +25.0% |
| Q3 2018 | $1,779,708 | -99.6% | 100,435 | +334.7% | 0.03% | +300.0% |
| Q2 2018 | $497,177,000 | +2.8% | 23,103 | +5.8% | 0.01% | +14.3% |
| Q1 2018 | $483,778,000 | +73646.6% | 21,841 | +1.2% | 0.01% | -22.2% |
| Q4 2017 | $656,000 | +24.2% | 21,589 | -0.9% | 0.01% | +200.0% |
| Q3 2017 | $528,000 | +3.7% | 21,792 | +5.4% | 0.00% | -25.0% |
| Q2 2017 | $509,000 | -84.8% | 20,680 | -86.6% | 0.00% | -82.6% |
| Q1 2017 | $3,356,000 | +39.4% | 154,882 | -4.1% | 0.02% | +35.3% |
| Q4 2016 | $2,407,000 | +16.4% | 161,424 | -0.2% | 0.02% | +13.3% |
| Q3 2016 | $2,068,000 | +61.2% | 161,724 | -1.6% | 0.02% | +50.0% |
| Q2 2016 | $1,283,000 | +102.7% | 164,278 | +3.9% | 0.01% | +100.0% |
| Q1 2016 | $633,000 | -28.6% | 158,163 | +0.5% | 0.01% | -28.6% |
| Q4 2015 | $887,000 | +0.5% | 157,343 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $883,000 | +119.7% | 157,343 | +47.0% | 0.01% | +100.0% |
| Q2 2015 | $402,000 | +1.8% | 107,039 | -30.3% | 0.00% | 0.0% |
| Q1 2015 | $395,000 | +78.7% | 153,615 | -0.1% | 0.00% | +50.0% |
| Q4 2014 | $221,000 | -6.0% | 153,763 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $235,000 | -36.8% | 153,763 | +40.2% | 0.00% | -33.3% |
| Q2 2014 | $372,000 | -28.7% | 109,657 | -25.6% | 0.00% | -25.0% |
| Q1 2014 | $522,000 | -43.3% | 147,390 | -1.9% | 0.00% | -33.3% |
| Q4 2013 | $921,000 | +5.3% | 150,269 | 0.0% | 0.01% | -14.3% |
| Q3 2013 | $875,000 | +43.0% | 150,269 | +11.5% | 0.01% | +40.0% |
| Q2 2013 | $612,000 | – | 134,727 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |